Neuroscience Research on Drug Abuse(R03) | Apply Online

Opportunity Summary:

The Neuroscience Research on Drug Abuse (R03) funding opportunity (PA 07 228) is a National Institutes of Health (NIH) grant program led by the National Institute on Drug Abuse (NIDA) that supports small-scale neuroscience and behavioral neuroscience studies aimed at improving scientific understanding of drug abuse and addiction. The scientific focus is broad but clearly centered on the biological and behavioral mechanisms that drive the full addiction cycle, including initial drug use, escalation, dependence, addiction, withdrawal, and responses to treatment. Projects can be conducted in a range of research settings and approaches, including studies using model systems, animal models, and human participants, as long as the work directly informs the neuroscience of substance use and addiction.

This opportunity uses the NIH Research Project Grant (R03) mechanism, which is designed for concise, tightly scoped research efforts rather than large, multi-year programs of work. NIDA highlights that R03 awards are well suited for pilot and feasibility studies that generate early data, secondary analyses of existing datasets, small self-contained projects with a limited set of aims, and the development of research methods or new technologies that can advance addiction neuroscience. In practical terms, the R03 mechanism is often used to test a promising idea, validate an approach, refine measures, or establish proof-of-concept findings that could later support a larger application.

The announcement notes that this R03 solicitation runs in parallel with companion funding opportunities that share the same scientific scope but use different NIH mechanisms: an R01 version (PA 07 226) for larger, more comprehensive projects and an R21 version (PA 07 227) for exploratory or developmental research. It also points applicants to a related pathway under the Academic Research Enhancement Award (R15), which targets institutions that have not traditionally received extensive NIH research funding. Together, these parallel options allow applicants to select a grant mechanism that matches the maturity, scale, and risk level of their proposed research while staying within the same overall topic area of addiction neuroscience.

Key administrative details include that the program is categorized as a discretionary grant, tied to CFDA number 93.279 (Drug Abuse and Addiction Research Programs), and does not require cost sharing or matching funds. The listed award ceiling is $50,000, consistent with the small-grant nature of the R03 mechanism. The opportunity was originally posted on February 22, 2007, with multiple application receipt dates, and the final listed closing date was May 7, 2010, with an archive date of June 7, 2010. While those dates indicate this specific posting is historical, the description still captures the intended purpose and the kinds of projects NIDA sought to support under this mechanism.

Eligibility is broad and inclusive. Eligible applicants include a wide range of domestic organizations such as state and local governments, tribal governments and tribal organizations, public and private institutions of higher education, nonprofit organizations (including those with or without 501(c)(3) status), small businesses, other for-profit entities (excluding small businesses only where specified), school districts, housing authorities, and special district governments. The announcement also specifies that foreign institutions are eligible to apply, that eligible federal agencies may apply, and that faith-based or community-based organizations may apply, provided they meet NIH eligibility requirements. For additional operational details, the full announcement was hosted on the NIH Grants Guide website, with support contacts routed through the NIH Office of Extramural Research (OER) webmaster for access or linking issues.

Browse more business programs for Drug Abuse Research and Prevention

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Collaborative Clinical Trials in Drug Abuse (R01)

Previous opportunity: Neuroscience Research on Drug Abuse (R21)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 07 228

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 07 228) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 228", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.